Clare Kahn - Net Worth and Insider Trading
Clare Kahn Net Worth
The estimated net worth of Clare Kahn is at least $6,534 dollars as of 2024-11-06. Clare Kahn is the Director of Solid Biosciences Inc and owns about 1,100 shares of Solid Biosciences Inc (SLDB) stock worth over $6,534. Details can be seen in Clare Kahn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Clare Kahn has not made any transactions after 2024-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Clare Kahn
Clare Kahn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Clare Kahn owns 1 companies in total, including Solid Biosciences Inc (SLDB) .
Click here to see the complete history of Clare Kahn’s form 4 insider trades.
Insider Ownership Summary of Clare Kahn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SLDB | Solid Biosciences Inc | 2024-06-07 | director |
Clare Kahn Latest Holdings Summary
Clare Kahn currently owns a total of 1 stock. Clare Kahn owns 1,100 shares of Solid Biosciences Inc (SLDB) as of June 7, 2024, with a value of $6,534.
Latest Holdings of Clare Kahn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SLDB | Solid Biosciences Inc | 2024-06-07 | 1,100 | 5.94 | 6,534 |
Holding Weightings of Clare Kahn
Clare Kahn Form 4 Trading Tracker
According to the SEC Form 4 filings, Clare Kahn has made a total of 1 transactions in Solid Biosciences Inc (SLDB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Solid Biosciences Inc is the acquisition of 1,100 shares on June 7, 2024, which cost Clare Kahn around $8,437.
Insider Trading History of Clare Kahn
- 1
Clare Kahn Trading Performance
GuruFocus tracks the stock performance after each of Clare Kahn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Clare Kahn is 0.62%. GuruFocus also compares Clare Kahn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Clare Kahn within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Clare Kahn's insider trading performs compared to the benchmark.
Performance of Clare Kahn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -27.17 |  | | | | |
| Relative Return to S&P 500(%) | -31.29 | | | | | |
Clare Kahn Ownership Network
Ownership Network List of Clare Kahn
Ownership Network Relation of Clare Kahn
Clare Kahn Owned Company Details
What does Solid Biosciences Inc do?
Who are the key executives at Solid Biosciences Inc?
Clare Kahn is the director of Solid Biosciences Inc. Other key executives at Solid Biosciences Inc include Chief Medical Officer Gabriel Brooks , director & Chief Executive Officer Ilan Ganot , and director & 10 percent owner Ra Capital Healthcare Fund Lp .
Solid Biosciences Inc (SLDB) Insider Trades Summary
Over the past 18 months, Clare Kahn made 1 insider transaction in Solid Biosciences Inc (SLDB) with a net purchase of 1,100. Other recent insider transactions involving Solid Biosciences Inc (SLDB) include a net sale of 1,743 shares made by Ilan Ganot , a net purchase of 3,410,713 shares made by Perceptive Life Sciences Master Fund Ltd , and a net purchase of 904,160 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 2,923 shares of Solid Biosciences Inc (SLDB) in total and bought 0 shares, with a net sale of 2,923 shares. During the past 18 months, 26,705 shares of Solid Biosciences Inc (SLDB) were sold and 4,315,973 shares were bought by its insiders, resulting in a net purchase of 4,289,268 shares.
Solid Biosciences Inc (SLDB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Solid Biosciences Inc Insider Transactions
Clare Kahn Mailing Address
Above is the net worth, insider trading, and ownership report for Clare Kahn. You might contact Clare Kahn via mailing address: 141 Portland Street, Fifth Floor, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
